A prospective study to explore the efficacy of brachytherapy using PET/MR for cervical cancer

A prospective study to explore the efficacy of brachytherapy using PET/MR for locally advanced cervical cancer - A prospective study to explore the efficacy of brachytherapy using PET/MR for cervical cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000057557

Enrollment

Registered

2025-04-08

Start date

2025-04-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Performing PET/MR before brachytherapy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) Histologically confirmed as squamous cell carcinoma, adenosquamous cell carcinoma, or adenocarcinoma 2) Aged 20 years or over 3) Primary tumor involves parametrium, adjacent organ, or uterus 4) Capable of maintaining a supine position 5) No prior radiation therapy to the pelvis

Exclusion criteria

Exclusion criteria: 1) Previous history of hysterectomy 2) Refusal of brachytherapy 3) Fasting blood glucose level of 200 mg/dL or higher 4) Currently using insulin 5) Difficulties in MR imaging due to claustrophobia 6) Presence of metal in the body that is contraindicated for MR imaging 7) The investigator is deemed unsuitable to participate in this study

Design outcomes

Primary

Measure	Time frame
Difference in residual tumor volume identified by PET/MR and MR	—

Countries

Japan

Contacts

Public ContactShinya Hiraoka

Kyoto University Hospital Department of Radiation Oncology

shiraok@kuhp.kyoto-u.ac.jp+81-75-751-3762

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026